ongenital heart disease (CHD) is one of the most commonly occurring congenital anomalies in the general population. In patients with Diamond Blackfan anemia (DBA)-a rare inherited bone marrow failure syndrome-CHD represents ≈30% of all congenital anomalies.
The patient was born at term with complex CHD; double outlet right ventricle, complete atrioventricular canal, and pulmonary stenosis with heterotaxy syndrome (asplenia, levocardia, juxtaposition of the aorta and inferior vena cava, right-sided stomach, and intestinal malrotation). Complete blood count at
Figure. Congenital heart disease (CHD) in Diamond Blackfan anemia (DBA).
A, The CHD anomalies in the Diamond Blackfan Anemia Registry (DBAR) included ventricular septal defect (VSD; 44%), atrial septal defect (ASD; 32.5%), coarctation of the aorta (CoA; 4.4%), pulmonic valve stenosis (PS; 5.3%), tetralogy of Fallot (TOF; 3.5%), aortic valve stenosis (AS; 2.6%), total anomalous pulmonary venous return (TAPVR; 0.9%), and others (7%). Patent ductus arteriosus and patent foramen ovale were not included. The defects were similar in relative frequency to those found in the general CHD population, 3 with VSD, ASD, CoA, PS, and TOF being the 5 most common CHD diagnoses in the DBAR but with the exception that there were no cases of tricuspid atresia (TVA), pulmonary atresia (PVA), hypoplastic left heart syndrome (HLHS), dextro-transposition of the great arteries (D-TGA), truncus arteriosus (TA), or atrioventricular canal (AVC). Because of the limited size, it is difficult to ascertain whether any of the diagnoses not found are truly underrepresented in the DBAR. However, restricting the analysis to age ≥6 mo likely precludes representative enrollment of patients with severe fatal lesions. The absence of AVC defects in the DBAR cohort can be explained by the fact that most AVC defects in the general population are usually seen in relation to syndromes, in particular, Down syndrome. B, Northern blot analysis of pre-rRNA processing was performed on total RNA isolated from primary peripheral blood mononuclear cells (left) on the DBAR patient and immortalized lymphoblastoid cells lines (right) from the Italian patient and healthy controls, respectively. Protein translations of mutational genotypes for index patients are shown above appropriate lanes. The membranes were interrogated with a probe against the 5′ end of internal spacer region 1 represented as the asterisk above the schematic views of pre-rRNA species shown to the right. The values shown below each lane represent the ratio of phosphorimage units derived for 30S and 18SE species in each lane demonstrate increased 30S pre-rRNA and diminished 18SE, consistent with a pre-rRNA processing defect reported in patients with RPS24 mutations.
15 months of age revealed hemoglobin, 17.5 g/dL; hematocrit, 51.3%; mean corpuscular volume, 87.3 fL; and reticulocyte count, 1.8%, at 3.5 years of age, he remains hematologically normal. Genetic testing revealed the same RPS24 mutation in the father who has an essentially normal complete blood count and no CHD.
The analysis was extended to patients within the Italian Italian DBA registry where 1 patient had an atrioventricular canal defect and a mutation in RPS24, c.64C>T (p.Gln22Ter). This variant was inherited by this patient's son who also had an atrioventricular canal defect, elevated erythrocyte adenosine deaminase activity, and abnormal rRNA processing (Figure) but no overt hematologic abnormalities.
In summary, CHD is significantly more prevalent among those with DBA than in the general population, and subclinical blood abnormalities characteristic of variably penetrant DBA may be detectable among those patients with CHD, supporting that they are linked. The distribution of CHD in patients with DBA seems to be similar to the general population. We identify 2 individuals from unrelated families with mutations in RPS24 for whom CHD is the only clinical manifestation of DBA. Both have mutations suggestive of loss of function with incomplete penetrance in both the hematologic and CHD phenotypes.
Elevated erythrocyte adenosine deaminase activity in unselected patients with CHD was noted in 5 of 102 patients with 1 confirmed to have occult DBA caused by a loss-of-function RPS24 mutation. Further analysis of other CHD cohorts will be necessary to estimate the prevalence of DBA in the general CHD population because the variable penetrance of the DBA phenotype can be associated with the occurrence of congenital anomalies without the classic hematologic findings.
Changes in the dosage of genes that transcriptionally regulate cardiogenesis have been proposed to lead to CHD. 5 The similarity in distribution of CHD in both the DBAR and general population suggests that disrupted translation caused by RP haploinsufficiency in DBA, similarly reducing gene dosage, may be an unrecognized cause of CHD. Studies to detect loss-of-function germline mutations in RP genes in patients with CHD are likely to reveal additional patients similar to those described herein. 
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